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Alteration of defibrillation threshold by antiarrhythmic drugs:  
a theoretical framework 
 
Charles F. Babbs, M.D., M.S., Ph.D. 
 
Biomedical Engineering Center, Purdue University, West Lafayette, Indiana, USA. 
 
[Critical Care Medicine, Vol. 9, No.5, pp. 362-363, 1981]  
 
Drugs may alter the ventricular defibrillation threshold, either to make resuscitation easier or 
more difficult. Assuming that cardiac defibrillation is essentially large scale stimulation of non-
refractory areas in the fibrillating muscle mass [1], the action of cardiac drugs can be understood 
theoretically in terms of their influence on the transmembrane sodium and potassium currents, 
INa and IK. The magnitudes of these ionic currents are functions of the transmembrane potential, 
Em, as shown in Figure 1(a).  
 
 
FIG. l. Balance of inward sodium and outward potassium currents in ventricular cells 
during diastole. (a) Absolute values of sodium and potassium currents as a function of 




Here gNa and gK denote sodium and potassium conductances of the membrane, and ENa and EK 
denote Nernst equilibrium potentials. The solid curve denoting sodium current is concave 
upwards because of the voltage dependence of fast sodium channels. 
 
Depolarization itself induces a sudden increase in gNa; while at this stage of the cardiac cycle, gK 
is essentially constant. The sodium and potassium current curves, therefore, cross at two points 
where inward sodium current and outward potassium current are equal. One point represents a 
stable equilibrium--the resting membrane potential, Er. The other is an unstable equilibrium--the 
cellular firing threshold, Eth. These two points divide the transmembrane potential domain into 
three zones, labeled 1, 2, and 3 in Figure l(a).  
 
The intensity of the electrical stimulus required to excite the ventricular muscle cell is related to 
the width of zone 2. As illustrated in Figure 1(b), if Em is transiently driven into either zone 1 or 
zone 2, it will return to the stable equilibrium value, Er, driven by the net ionic current. However, 
if Em is driven past the cellular firing threshold into zone 3, an action potential will be initiated 
and the cell will become refractory. The intensity of the stimulus required to excite the cell in 
this way depends upon the extent of zone 2. 
 
In theory, drugs that increase gK or decrease gNa will widen zone 2 (Eth  Er) and so increase the 
strength of the stimulus required for excitation. In turn, these drugs will increase the 
defibrillation threshold. Drugs that decrease gK or increase gNa will narrow zone 2 and reduce the 
defibrillation threshold.  
 
The authors have studied a variety of antiarrhythmic drugs to determine their effect on 
ventricular defibrillation threshold in dogs. Drugs that decrease sodium conductance, such as 
quinidine, or that increase potassium conductance, such as lidocaine, raise the defibrillation 
threshold [2]. The new antifibrillatory drug, cloftlium (LY 150387), which decreases potassium 
conductance and prolongs the action potential duration, in fact lowers defibrillation threshold, as 
predicted from theory. Digitalis glycosides, which act by inhibiting the membrane bound 
sodium-potassium "pump" and reduce the net outward sodium current, also lower the 
defibrillation threshold.  
 
One final ionic mechanism should be mentioned.  Shift of the potassium equilibrium potential. 
EK depends upon the (log Ko/Ki), where Ko and Ki represent extracellular and intracellular 
potassium concentrations. Moderate elevation of extracellular potassium concentration makes EK 
less negative, shifting the dashed line for potassium current in Figure l(a) to the right without 
changing its slope. This effect decreases the extent of zone 2 and increases excitability. Infusion 
of potassium chloride in dogs is known to lower defibrillation threshold, and at a critical level of 
Ko spontaneous defibrillation occurs [5]. Extremely high levels of Ko, which cause a shift of the 
potassium current line completely to the right of the sodium current curve, make the cell 
inexcitable, because a normal resting potential cannot be restored. This last state may exist 
during the use of "cardioplegic" solutions to immobilize the heart at surgery.  
 







Evidently, the actions of cardiac drugs on the defibrillation threshold can be understood in terms 
of basic electrophysiology. In practice, classical antiarrhythmic drugs do not reduce the 
defibrillation threshold and should not be given for this purpose. Potassium doses lower 
threshold but also produces an unwanted negative inotropic effect. Digitalis lowers threshold, but 
only at toxic doses. Newer agents, such as clofilium, which act by other than a local anesthetic 
mechanism, may have the dual advantage of reducing defibrillation threshold while preventing 
recurrent episodes of fibrillation. Such drugs may offer a special theoretical advantage for the 
hospitalized patient with recurrent ventricular fibrillation and may even be of value when 
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